Second terms for US presidents tend to wind up being plagued with scandals of one sort or another, and you probably won’t be terribly surprised if the same thing comes to pass for Barack Obama. But what form will the scandal take? Benghazi? Fast and Furious? Something to do with the UN? All of those are still possible of course, but there’s a new story slowly bubbling to the surface right now, and it involves…. genetically modified fish.
The Food and Drug Administration released long-awaited documents Dec. 21 on genetically modified salmon: an assessment of the fish’s potential environmental effects and a preliminary “finding of no significant impact” of the fish on the environment. This brings AquAdvantage salmon — Atlantic salmon that has been modified with a growth hormone gene from chinook salmon so that it reaches maturity faster — a significant step closer to FDA approval.
Astute readers will notice that the recently released documents are dated May 4. So why were they just released Dec. 21 — seven months later?
In a Dec. 21 email, a spokesperson for the FDA explained it this way: “Yes there was a delay. As you are aware, we’ve been working on this for a while, and it was an oversight in our [quality control] process. We are working to address it now.”
You’re to be forgiven if this story – thus far – sounds about as exciting as watching paint dry. The genetic modification to the salmon apparently just allows them to grow to maturity much faster than regular fish, so it’s not like they have lasers in their heads or anything. But this particular FDA study – at least according to some sources – was actually concluded nearly two years ago. After those delays, it was allegedly really ready for release back in May. And yet it was released quietly on Friday, Dec. 21st, just as everyone was heading out for Christmas. Something smells fishy there, if you’ll pardon the pun.